Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000612878 | SCV000728104 | likely benign | not specified | 2018-03-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV002066632 | SCV002409174 | benign | not provided | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002413752 | SCV002720851 | benign | Cardiovascular phenotype | 2021-10-28 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV003758887 | SCV004562470 | benign | Cardiomyopathy, familial hypertrophic 27 | 2023-08-31 | criteria provided, single submitter | clinical testing |